NCT02093104
- Conditions
- Undergoing Chemoembolization and Radioembolization, Unresectable Hepatocellular Carcinoma
- Locations
-
- Vancouver General Hospital Vancouver, British Columbia, Canada
Clinical trial condition
Unresectable Hepatocellular Carcinoma
Explore clinical trials studying Unresectable Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
57 public trials
17 recruiting studies
Unresectable Hepatocellular Carcinoma trial results
NCT00829465
- Conditions
- Unresectable Hepatocellular Carcinoma
- Locations
-
Not specified
NCT00988741
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
- Locations
-
- Los Angeles, California, United States
- Tampa, Florida, United States
- Galveston, Texas, United States
- Brussels, Belgium
NCT00247676
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Liver Diseases, +4 more
- Locations
-
- Pfizer Investigational Site Clichy, France
- Pfizer Investigational Site Rennes, France
- Pfizer Investigational Site Saint Herrblain Cedex, France
- Pfizer Investigational Site Seoul, South Korea
NCT06117891
- Conditions
- Unresectable Hepatocellular Carcinoma
- Locations
-
- Mercy Medical Center - Medline Healthcare Services LLC Baltimore, Maryland, United States
- University of Michigan Health System Ann Arbor, Michigan, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
- University Of Cincinnati Division Of Hematology Oncology - UC Health System Cincinnati, Ohio, United States
Active, Not Recruiting
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
NCT04175912
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, Not Recruiting
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
NCT03186898
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Emory Proton Therapy Center Atlanta, Georgia, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
Active, Not Recruiting
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
NCT06900543
- Conditions
- Unresectable Hepatocellular Carcinoma
- Locations
-
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
- The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
- The First Affiliated Hospital of Jinan University Guangzhou, Guangdong, China
Active, Not Recruiting
Donafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular Carcinoma
NCT05507632
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
Active, Not Recruiting
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
NCT03896646
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States